Loading Page
Dr. Ralph R. Weichselbaum, MD is a radiation oncologist in Chicago, IL specializing in radiation oncology. He graduated from University of Illinois College of Medicine. Dr. Ralph R. Weichselbaum, MD is affiliated with The University of Chicago Medicine.
5758 S. Maryland Avenue
Chicago, IL 60637
Dr. Ralph R. Weichselbaum, MD graduated from University of Illinois College of Medicine. He completed residency at Harvard University Affiliated Hospitals. He is certified by the Board Certification: Nuclear and has a state license in Massachusetts.
Medical School: University of Illinois College of Medicine
Residency: Harvard University Affiliated Hospitals
Board Certification: Board Certification: Nuclear
Licensed In: Massachusetts
Dr. Ralph R. Weichselbaum, MD is associated with these hospitals and organizations:
Dr. Ralph R. Weichselbaum, MD appears to accept the following insurance providers: Blue Cross Blue Shield PPO, Aetna PPO, CIGNA PPO, CIGNA POS, CIGNA HMO, MultiPlan PPO, Medicare Advantage, Aetna POS, Medicare, Humana, PHCS PPO, Aetna Medicare PPO, United W500 Emergent Wrap, Aetna Better Health *see insurance page, United Options (PPO), CountyCare *see insurance page, BCBS HMO (HMOI) (specialists only), United Select (HMO & EPO) (specialists only), University of Chicago Health Plan (UCHP), United Choice HMO (specialists only), BCBS Blue Precision HMO (specialists only), Aetna HMO (specialists only) and United Choice Plus POS/PPO.
According to our sources, Dr. Ralph R. Weichselbaum, MD accepts the following insurance providers:
Dr. Ralph R. Weichselbaum, MD does not have any reviews yet, be the first to leave a review of Dr. Ralph R. Weichselbaum, MD here: Leave a Review
These charts describe general payments received by Dr. Ralph R. Weichselbaum, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$9,417
Avelumab $4,270 |
$5,147 |
|
|
$5,895
IMFINZI $5,895 |
||
|
$3,382
$3,382 |
||
|
$1,605
$1,605 |
||
|
$1,000
$1,000 |
||
|
$1,048
TrueBeam $68 |
$979 |
| $16,720 | |
| $2,035 | |
| $2,000 | |
| $1,000 | |
| $591 |
Dr. Ralph R. Weichselbaum, MD has received 27 research payments totaling $896,519.
This table describes ownership payments received by Dr. Ralph R. Weichselbaum, MD.
| RefleXion Medical, Inc. | 2022 | $54,920.01 | Physician Covered Recipient | 24999.98 Paid 1.08 Per Share |
| RefleXion Medical, Inc. | 2022 | $54,920.01 | Physician Covered Recipient | 24999.98 Paid 1.08 Per Share |
| RefleXion Medical, Inc. | 2021 | $52,834.44 | Physician Covered Recipient | 24999.98 Total Paid 1.08 Price Per Share |
| RefleXion Medical, Inc. | 2021 | $52,834.44 | Physician Covered Recipient | 24999.98 Total Paid 1.08 Price Per Share |
| RefleXion Medical, Inc. | 2022 | $37,739.88 | Physician Covered Recipient | 5477.54 Paid .34 Per Share |
| RefleXion Medical, Inc. | 2021 | $36,306.72 | Physician Covered Recipient | 5477.54 Total Paid 0.34 Price Per Share |
| RefleXion Medical, Inc. | 2021 | $28,000.00 | Physician Covered Recipient | 400 Total Paid 0.70 Price Per Share |
| RefleXion Medical, Inc. | 2022 | $22,800.00 | Physician Covered Recipient | 400 Paid .01 Per Share |
| RefleXion Medical, Inc. | 2023 | $13,600.00 | Physician Covered Recipient | Common Stock |
| RefleXion Medical, Inc. | 2023 | $9,037.47 | Physician Covered Recipient | Series B Preferred |
| RefleXion Medical, Inc. | 2023 | $9,037.47 | Physician Covered Recipient | Series B Preferred |
| RefleXion Medical, Inc. | 2023 | $5,732.64 | Physician Covered Recipient | Series A Preferred |
| RefleXion Medical, Inc. | 2022 | $3,443.61 | Physician Covered Recipient | 499.80 Paid .34 Per Share |
| RefleXion Medical, Inc. | 2021 | $3,312.84 | Physician Covered Recipient | 499.80 Total Paid 0.34 Price Per Share |
| RefleXion Medical, Inc. | 2023 | $523.08 | Physician Covered Recipient | Series A Preferred |
| RefleXion Medical, Inc. | 2023 | $0.00 | Physician Covered Recipient | Common stock option that was exercised |
| RefleXion Medical, Inc. | 2023 | $0.00 | Physician Covered Recipient | Series A Preferred warrant that was exercised |
Dr. Ralph Weichselbaum is a radiation oncology specialist. He has a special interest in immunotherapy, rectal cancer, and pancreatic cancer. Blue California, Aetna, and CIGNA Plans appears to be the insurance carriers that Dr. Weichselbaum takes. Dr. Weichselbaum attended medical school at the University of Illinois College of Medicine. For his professional training, Dr. Weichselbaum completed a residency program at a hospital affiliated with Harvard University. Dr. Weichselbaum is affiliated with The University of Chicago Medicine.
